$PPSI
PIONEER POWER SOLUTIONS, INC. Stock $ppsi

$ppsi Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224040481 Filed on October 08, 2024

Income Statement

Concept	2024 Q4	2024 Q2	2023 Q2
Revenue		$6.340M	$12.13M
YoY Change		-47.73%	182.82%
Cost Of Revenue		$5.687M	$9.419M
YoY Change		-39.62%	123.84%
Gross Profit		$653.0K	$2.711M
YoY Change		-75.91%	3246.91%
Gross Profit Margin		10.3%	22.35%
Selling, General & Admin		$2.715M	$3.089M
YoY Change		-12.11%	19.5%
% of Gross Profit		415.77%	113.94%
Research & Development		$238.0K
YoY Change
% of Gross Profit		36.45%
Depreciation & Amortization		$164.0K	$97.00K
YoY Change		69.07%	162.16%
% of Gross Profit		25.11%	3.58%
Operating Expenses		$2.953M	$3.089M
YoY Change		-4.4%	19.5%
Operating Profit		-$2.300M	-$378.0K
YoY Change		508.47%	-84.9%
Interest Expense		$17.00K	$79.00K
YoY Change		-78.48%	-24.04%
% of Operating Profit
Other Income/Expense, Net			-$20.00K
YoY Change			-82.91%
Pretax Income		-$2.283M	-$319.0K
YoY Change		615.67%	-87.33%
Income Tax
% Of Pretax Income
Net Earnings		-$2.283M	-$319.0K
YoY Change		615.67%	-87.33%
Net Earnings / Revenue		-36.01%	-2.63%
Basic Earnings Per Share		-$0.21	-$0.03
Diluted Earnings Per Share		-$0.21	-$0.03
COMMON SHARES
Basic Shares Outstanding	10.92M shares	10.92M shares	9.768M shares
Diluted Shares Outstanding		10.92M shares	9.908M shares

Balance Sheet

Concept	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.512M	$9.624M
YoY Change	-32.34%	-1.65%
Cash & Equivalents	$6.512M	$9.624M
Short-Term Investments
Other Short-Term Assets	$7.946M	$2.625M
YoY Change	202.7%	144.41%
Inventory	$12.66M	$8.457M
Prepaid Expenses
Receivables	$5.900M	$5.835M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$33.02M	$26.54M
YoY Change	24.39%	-14.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.226M	$2.383M
YoY Change	77.34%	284.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$75.00K	$138.0K
YoY Change	-45.65%	72.5%
Total Long-Term Assets	$5.009M	$4.154M
YoY Change	20.58%	36.82%
TOTAL ASSETS
Total Short-Term Assets	$33.02M	$26.54M
Total Long-Term Assets	$5.009M	$4.154M
Total Assets	$38.02M	$30.70M
YoY Change	23.88%	-10.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.520M	$5.542M
YoY Change	-0.4%	32.24%
Accrued Expenses	$6.987M	$1.249M
YoY Change	459.41%	0.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$123.0K	$192.0K
YoY Change	-35.94%	-44.35%
Total Short-Term Liabilities	$21.88M	$12.18M
YoY Change	79.63%	-22.41%
LONG-TERM LIABILITIES
Long-Term Debt	$200.0K	$353.0K
YoY Change	-43.34%	-31.85%
Other Long-Term Liabilities	$40.00K	$57.00K
YoY Change	-29.82%	-96.04%
Total Long-Term Liabilities	$40.00K	$57.00K
YoY Change	-29.82%	-96.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.88M	$12.18M
Total Long-Term Liabilities	$40.00K	$57.00K
Total Liabilities	$22.24M	$13.01M
YoY Change	70.9%	-24.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.95M	-$16.15M
YoY Change	42.11%	3.39%
Common Stock	$11.00K	$10.00K
YoY Change	10.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.79M	$17.68M
YoY Change
Total Liabilities & Shareholders Equity	$38.02M	$30.70M
YoY Change	23.88%	-10.03%

Cashflow Statement

Concept	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$2.283M	-$319.0K
YoY Change	615.67%	-87.33%
Depreciation, Depletion And Amortization	$164.0K	$97.00K
YoY Change	69.07%	162.16%
Cash From Operating Activities	$571.0K	-$1.159M
YoY Change	-149.27%	-68.74%
INVESTING ACTIVITIES
Capital Expenditures	$401.0K	$616.0K
YoY Change	-34.9%	-1093.55%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$401.0K	-$616.0K
YoY Change	-34.9%	893.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	115.0K	-157.0K
YoY Change	-173.25%	78.41%
NET CHANGE
Cash From Operating Activities	571.0K	-1.159M
Cash From Investing Activities	-401.0K	-616.0K
Cash From Financing Activities	115.0K	-157.0K
Net Change In Cash	285.0K	-1.932M
YoY Change	-114.75%	-49.92%
FREE CASH FLOW
Cash From Operating Activities	$571.0K	-$1.159M
Capital Expenditures	$401.0K	$616.0K
Free Cash Flow	$170.0K	-$1.775M
YoY Change	-109.58%	-51.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001449792
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Other Noncash Income OtherNoncashIncome		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	PPSI	Surrender And Retirement Of Common Stock SurrenderAndRetirementOfCommonStock		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedFairValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedFairValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2024Q2	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedFairValue		usd
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35212
	dei	Entity Registrant Name EntityRegistrantName	PIONEER POWER SOLUTIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1347616
	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Kelby Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Lee
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07024
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	867-0700
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	PPSI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10917038	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21838000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15127000	usd
	us-gaap	Gross Profit GrossProfit	6711000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5246000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	238000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	449000	usd
	us-gaap	Operating Expenses OperatingExpenses	5246000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1465000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	132000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1590000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9838989	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10677156	shares
CY2023Q4	us-gaap	Cash Cash	3582000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	150000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	97000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9010000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	7579000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7512000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	27683000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3899000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	760000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	403000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	195000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82000	usd
CY2023Q4	us-gaap	Assets Assets	33022000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12609000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	139000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4932000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18262000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	215000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	278000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	49000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	18804000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10917038	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10917038	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9930022	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9930022	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33837000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19629000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14218000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33022000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
	us-gaap	Depreciation Depreciation	227000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	205000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	340000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	44000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	962000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	13000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3774000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	295000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-224000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-449000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5896000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-343000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	366000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	810000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-810000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4986000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	63000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	228000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4923000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-228000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2930000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-672000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3582	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10296	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6512000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9624000	usd
	us-gaap	Interest Paid Net InterestPaidNet	18000	usd
	PPSI	Surrender And Retirement Of Common Stock SurrenderAndRetirementOfCommonStock	224000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16023000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	848000	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	819000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17690000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18059000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2283000	usd
CY2024Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	96000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	140000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	224000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15788000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15152000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	962000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-14000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17690000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14218000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14218000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3318000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3318000	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	321000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4791000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	224000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15788000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15788000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2024Q2	PPSI	Deferred Tax Assets Valuation Allowance Percentage DeferredTaxAssetsValuationAllowancePercentage	1	pure
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6512000	usd
CY2024Q2	PPSI	Working Capital Deficit WorkingCapitalDeficit	11140000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	7500000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	150000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	97000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	98000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3334000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2477000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5966000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6340000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12282000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14930000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21838000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	10346000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5316000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2311000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2263000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	12657000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	7579000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7084000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6470000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2858000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2571000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4226000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3899000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	164000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	97000	usd
	us-gaap	Depreciation Depreciation	286000	usd
	us-gaap	Depreciation Depreciation	227000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5520000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5396000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6987000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7213000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12507000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12609000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5000000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5000000	usd
CY2024Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	584000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	442000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	252000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	294000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	167000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	67000	usd
CY2024Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	228000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	795000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	706167	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5146	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.89
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	57000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.21
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	654313	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.07
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	284000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	629670	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.00
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	284000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	125000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.35
CY2023Q4	PPSI	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedFairValue	543000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	125000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.35
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	543000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	96000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	321000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	819000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	962000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	109000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2283000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	848000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3318000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1590000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10920125	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9908434	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10518659	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9838989	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	838167	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	838167	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10920125	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10746601	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10518659	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10677156	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2024Q2	us-gaap	Revenues Revenues	6340000	usd
CY2023Q2	us-gaap	Revenues Revenues	12282000	usd
	us-gaap	Revenues Revenues	14930000	usd
	us-gaap	Revenues Revenues	21838000	usd
CY2024Q2	us-gaap	Revenues Revenues	6340000	usd
CY2023Q2	us-gaap	Revenues Revenues	12282000	usd
	us-gaap	Revenues Revenues	14930000	usd
	us-gaap	Revenues Revenues	21838000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	195000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	228000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	349000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	432000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	195000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	228000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	349000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	432000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2300000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	789000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3406000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1465000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2300000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	789000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3406000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1465000	usd
CY2024Q2	PPSI	Common Stock Adverse Party Percentage CommonStockAdversePartyPercentage	0.05	pure

Files In Submission

Name	View Source	Status
0001493152-24-040481-index-headers.html	Edgar Link	pending
0001493152-24-040481-index.html	Edgar Link	pending
0001493152-24-040481.txt	Edgar Link	pending
0001493152-24-040481-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ppsi-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ppsi-20240630_cal.xml	Edgar Link	unprocessable
ppsi-20240630_def.xml	Edgar Link	unprocessable
ppsi-20240630_pre.xml	Edgar Link	unprocessable
ppsi-20240630_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PPSI
PIONEER POWER SOLUTIONS, INC. Stock $ppsi

2024 Q4 Form 10-Q Financial Statement

#000149315224040481 Filed on October 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PPSI PIONEER POWER SOLUTIONS, INC. Stock $ppsi

2024 Q4 Form 10-Q Financial Statement

#000149315224040481 Filed on October 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PPSI
PIONEER POWER SOLUTIONS, INC. Stock $ppsi